WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012052748) METHOD FOR IMMUNISING A SUBJECT AGAINST MYCOBACTERIUM TUBERCULOSIS OR MYCOBACTERIUM BOVIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/052748    International Application No.:    PCT/GB2011/052005
Publication Date: 26.04.2012 International Filing Date: 17.10.2011
IPC:
A61K 39/04 (2006.01)
Applicants: ISIS INNOVATION LIMITED [GB/GB]; Ewert House Ewert Place Summertown Oxford Oxfordshire OX2 7SG (GB) (For All Designated States Except US).
BEVERLEY, Peter Charles Leonard [GB/GB]; (GB) (For US Only).
TCHILIAN, Elma Zaven [GB/GB]; (GB) (For US Only)
Inventors: BEVERLEY, Peter Charles Leonard; (GB).
TCHILIAN, Elma Zaven; (GB)
Agent: JA KEMP & CO; 14 South Square Gray's Inn London WC1R 5JJ (GB)
Priority Data:
1017574.3 18.10.2010 GB
1103952.6 08.03.2011 GB
Title (EN) METHOD FOR IMMUNISING A SUBJECT AGAINST MYCOBACTERIUM TUBERCULOSIS OR MYCOBACTERIUM BOVIS
(FR) MÉTHODE D'IMMUNISATION D'UN SUJET CONTRE MYCOBACTERIUM TUBERCULOSIS OU MYCOBACTERIUM BOVIS
Abstract: front page image
(EN)The invention relates to a method for immunising a subject against Mycobacterium tuberculosis ox Mycobacterium bovis. The method comprises parenterally administering to the subject an immunologically effective amount of a first antigen from the Mycobacterium or a first polynucleotide encoding the first antigen and administering to the lung of the subject an immunologically effective amount of a second antigen from the Mycobacterium or a second polynucleotide encoding the second antigen. The two administration steps are carried out less than four weeks apart. The invention also relates to a kit for carrying out the method of the invention.
(FR)L'invention concerne une méthode d'immunisation d'un sujet contre Mycobacterium tuberculosis ou Mycobacterium bovis. La méthode comprend l'administration parentérale au sujet d'une quantité immunologiquement efficace d'un premier antigène provenant du Mycobacterium ou d'un premier polynucléotide codant pour le premier antigène, et l'administration au poumon du sujet d'une quantité immunologiquement efficace d'un second antigène provenant du Mycobacterium ou d'un second polynucléotide codant pour le second antigène. Les deux étapes d'administration sont mises en œuvre à moins de quatre semaines l'une de l'autre. L'invention concerne également une trousse pour la mise en œuvre de la méthode de l'invention.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)